Zhao W, Yu D, Chen Z, Yao W, et al. Inhibition of MEK5/ERK5 signaling overcomes acquired resistance to the third generation EGFR inhibitor, osimertinib, via enhancing Bim-dependent apoptosis. Cancer Lett 2021;519:141-149.
PMID: 34245854